.png){kind=logo}
Grow DTC Campaigns. Protect Patient Data. Prove Performance Across the Full Patient Journey.
The Results Pharma & Device Marketers Achieve with Freshpaint
Solutions That Transform DTC Marketing
Reach the right patients at the right time with complaince retargeting and lookalike campaigns. Freshpaint removes sensitive health data before activating audiences and sending conversion signals back to ad platforms, so DTC growth continues without introducing new privacy risk.
- Reduce patient acquisition costs across DTC channels
- Run retargeting and lookalike campaigns without FTC violations
- Optimize ad platforms with real conversion data (scripts, activations)
- Scale winning campaigns without legal exposure
Connect ad spend to real business outcomes (e.g., scripts filled, devices activated, subjects recruited, patient enrollments completed). Freshpaint brings fragmented performance data together across all your social, CTV, programmatic, and endemic sites. This makes it possible to prove marketing ROI with attribution that actually reflects the complete patient journey.
- See which campaigns drive scripts, device activations, and subject recruitment
- Identify where measurement drops off across telehealth, fulfillment, and enrollment flows
- Defend performance with clear insights
- Tie brand awareness spend to bottom-funnel outcomes
Mitigate FTC enforcement risk and state law violations from your entire DTC funnel. Freshpaint replaces risky pixels, scripts, and trackers with a single compliant pixel across branded sites, clinical trial landing pages, co-pay programs, telehealth redirects, and trial kit flows. This helps you maintain full marketing capabilities while staying safe from evolving privacy laws.
- Built on a HIPAA-compliant foundation
- Eliminate class action lawsuit exposure from pixels
- Stay compliant with state privacy laws (CA, WA, CO, VA, etc.)
- Restore conversion tracking without regulatory risk
Real Impact From Leading Healthcare Organizations
Freshpaint gave us a privacy-compliant way to reconnect our marketing stack and re-optimize paid social without compromising our standards. Within months, we recovered 85–90% of lost lead volume, returned CPL to baseline, and are now scaling this approach globally.
.svg){kind=icon}
Purpose-Built for How You Market
Pharma brands rely on both branded and unbranded sites to educate, influence, and convert patients. Even though both play distinct roles (creative flexibility for early-funnel interest vs. specific value for driving actions), each can trigger FTC and state law risk when tracking pixels are used improperly, as demonstrated by California's Healthline case.
How Freshpaint Helps:
- Track which condition-specific pages drive conversions without exposing diagnosis
- Measure awareness campaign effectiveness across CTV, social, and programmatic
- Build audiences from educational content engagement without health context
- Comply with state "purpose limitation" requirements for sensitive data
Co-pay cards and patient savings programs drive significant script lift, but pixels on these pages create class action exposure. Plaintiffs' attorneys argue that tracking co-pay card activations for specific drugs exposes patient conditions to ad platforms.
How Freshpaint Helps:
- Track co-pay card eligibility, activations, and redemptions without drug-condition linkage
- Measure program ROI and script lift by channel without pixel risk
- Retarget eligible patients without exposing prescribed medications
- Maintain attribution across awareness campaigns through program enrollment
GLP-1 brands, flu vaccines, mental health medications, and specialty drugs increasingly redirect from branded sites to telehealth partners for virtual consultations and prescriptions. These cross-domain handoffs create the highest FTC risk because pixels fire at the exact moment patients seek treatment. Without proper controls, these transitions can inadvertently expose sensitive intent data.
How Freshpaint Helps:
- Track telehealth partner referrals without exposing patient intent
- Measure conversion from brand site visit through completed consultation
- Maintain attribution across domain boundaries without pixel risk
- Enable safe retargeting of consultation drop-offs
CGM manufacturers, diabetes brands, hearing aid brands, and sleep apnea device companies offer DTC purchasing workflows or free device trials to reduce purchase friction. But trial kit request forms or purchase workflows often require condition-specific information, and pixels capturing these requests expose patient health status to ad platforms.
How Freshpaint Helps:
- Track trial kit requests without capturing patient conditions
- Measure true ROI based on device activations, not just trial requests
- Build audiences of trial requesters who didn't activate for retargeting
- Connect brand awareness spend through trial requests to activation
Why Pharma & Device Brands Choose Freshpaint
Unlike traditional tracking tools that can release sensitive health data downstream, Freshpaint supports privacy-first DTC measurement by giving brands greater control and visibility into how data is collected and shared. This lets teams continue running performance-driven DTC campaigns while meeting higher standards for privacy across educational, awareness, and conversion experiences.
Freshpaint is designed to get teams live quickly without months of custom engineering or ongoing maintenance. Because privacy and performance are handled within the platform, marketers don’t need to constantly rework implementations as regulations, enforcement, or platform rules evolve.
Compliance has increasingly limited the DTC tactics marketing teams rely on. Freshpaint restores what those teams lose when pixels are removed by enabling compliant analytics, attribution, and media tracking that still support campaign optimization and business growth. Marketing teams can measure full funnel performance. Legal teams have confidence campaigns are compliant.
Rather than relying on generic documentation or reactive support, customers work with people who understand the regulatory landscape and the realities of running DTC programs in healthcare. This partnership helps teams move faster, avoid missteps, and continuously improve performance with confidence.
.svg)
